Auris Medical Holding Ltd. logo
Auris Medical Holding Ltd. EARS

Auris Medical Holding Ltd. Revenue 2011-2026 | EARS

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Auris Medical Holding Ltd.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
174 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
174 K 174 K 174 K

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Biotechnology industry

Issuer Revenue Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
238 M - 2.43 % $ 254 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
1.26 M - 2.71 % $ 14 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
118 M - -24.86 % $ 820 K usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
142 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
886 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
325 K - - $ 26.5 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
75.1 M $ 3.59 -1.24 % $ 1.07 B canadaCanada
I-Mab I-Mab
IMAB
88 M - - $ 866 M chinaChina
ADMA Biologics ADMA Biologics
ADMA
510 M $ 15.71 -5.02 % $ 3.74 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
6.07 B - - $ 40.3 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
912 K $ 0.82 -0.73 % $ 4.47 M chinaChina
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
381 K - -18.52 % $ 27.3 M britainBritain
Alpine Immune Sciences Alpine Immune Sciences
ALPN
30.1 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
165 K - 4.14 % $ 49.1 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
1 B $ 20.29 2.17 % $ 2.56 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
1.16 M - -11.43 % $ 502 K usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
614 M $ 75.95 -0.76 % $ 1.47 B usaUSA
Applied Therapeutics Applied Therapeutics
APLT
9.99 M - - $ 8.42 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
242 K $ 1.5 -7.98 % $ 383 M britainBritain
Aravive Aravive
ARAV
9.14 M - -13.39 % $ 1.45 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
1 M - - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.08 B - - - russiaRussia
Athersys Athersys
ATHX
5.51 M - 3.77 % $ 22.4 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
761 M $ 34.35 -3.74 % $ 3.57 B usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
42.3 M - - $ 521 M usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
882 K $ 7.99 -5.17 % $ 34.6 M usaUSA
CorMedix CorMedix
CRMD
65.4 K $ 6.35 -10.88 % $ 323 M usaUSA
Champions Oncology Champions Oncology
CSBR
56.9 M $ 5.79 -3.58 % $ 79.1 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
638 M $ 160.64 -2.1 % $ 7.99 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
502 M $ 65.51 -1.55 % $ 12.5 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
167 M - -4.8 % $ 255 M usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
331 M $ 19.73 -3.17 % $ 3.25 B usaUSA
Acasti Pharma Acasti Pharma
ACST
100 M - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
5.34 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Edesa Biotech Edesa Biotech
EDSA
329 K $ 3.71 -13.11 % $ 11.9 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
1.5 M - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
78.6 M - -7.31 % $ 87 M usaUSA
Equillium Equillium
EQ
36.1 M $ 1.79 2.29 % $ 62.2 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
48.9 M - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
9.59 M - 5.93 % $ 314 M canadaCanada
BioLineRx Ltd. BioLineRx Ltd.
BLRX
28.9 M $ 2.75 -1.96 % $ 908 M israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
3.22 B $ 60.6 0.28 % $ 11.6 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
330 M $ 8.26 -1.31 % $ 1.36 B britainBritain